vs
Chefs' Warehouse, Inc.（CHEF）与爵士制药（JAZZ）财务数据对比。点击上方公司名可切换其他公司
爵士制药的季度营收约是Chefs' Warehouse, Inc.的1.0倍（$1.2B vs $1.1B），爵士制药净利率更高（17.0% vs 1.9%，领先15.1%），Chefs' Warehouse, Inc.同比增速更快（10.5% vs 10.1%），爵士制药自由现金流更多（$345.8M vs $65.8M），过去两年爵士制药的营收复合增速更高（15.2% vs 14.3%）
Chefs' Warehouse, Inc. 是一家北美专业食品分销商，服务对象包括独立餐厅、高端餐饮场所、酒店、餐饮服务商等食品服务运营商，供应超15万种精选产品，涵盖手工食材、特色肉类、海鲜、乳制品、进口高端美食等，适配专业厨师的使用需求。
爵士制药是一家全球性生物制药企业，核心业务聚焦肿瘤学与神经科学两大领域，2003年在美国加利福尼亚州成立，当前总部坐落于爱尔兰首都都柏林。
CHEF vs JAZZ — 直观对比
营收规模更大
JAZZ
是对方的1.0倍
$1.1B
营收增速更快
CHEF
高出0.5%
10.1%
净利率更高
JAZZ
高出15.1%
1.9%
自由现金流更多
JAZZ
多$280.0M
$65.8M
两年增速更快
JAZZ
近两年复合增速
14.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.2B |
| 净利润 | $21.7M | $203.5M |
| 毛利率 | 24.2% | — |
| 营业利润率 | 3.8% | 21.2% |
| 净利率 | 1.9% | 17.0% |
| 营收同比 | 10.5% | 10.1% |
| 净利润同比 | -9.4% | 6.5% |
| 每股收益（稀释后） | $0.50 | $3.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHEFJAZZ
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.0B | $1.1B | ||
| Q2 25 | $1.0B | $1.0B | ||
| Q1 25 | $950.7M | $897.8M | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $931.5M | $1.1B | ||
| Q2 24 | $954.7M | $1.0B | ||
| Q1 24 | $874.5M | $902.0M |
净利润CHEFJAZZ
| Q4 25 | $21.7M | $203.5M | ||
| Q3 25 | $19.1M | $251.4M | ||
| Q2 25 | $21.2M | $-718.5M | ||
| Q1 25 | $10.3M | $-92.5M | ||
| Q4 24 | $23.9M | $191.1M | ||
| Q3 24 | $14.1M | $215.1M | ||
| Q2 24 | $15.5M | $168.6M | ||
| Q1 24 | $1.9M | $-14.6M |
毛利率CHEFJAZZ
| Q4 25 | 24.2% | — | ||
| Q3 25 | 24.2% | — | ||
| Q2 25 | 24.6% | — | ||
| Q1 25 | 23.8% | — | ||
| Q4 24 | 24.3% | — | ||
| Q3 24 | 24.1% | — | ||
| Q2 24 | 24.0% | — | ||
| Q1 24 | 23.9% | — |
营业利润率CHEFJAZZ
| Q4 25 | 3.8% | 21.2% | ||
| Q3 25 | 3.8% | 5.1% | ||
| Q2 25 | 3.9% | -65.6% | ||
| Q1 25 | 2.4% | -6.2% | ||
| Q4 24 | 4.5% | 17.5% | ||
| Q3 24 | 3.4% | 24.7% | ||
| Q2 24 | 3.5% | 19.5% | ||
| Q1 24 | 1.8% | 7.3% |
净利率CHEFJAZZ
| Q4 25 | 1.9% | 17.0% | ||
| Q3 25 | 1.9% | 22.3% | ||
| Q2 25 | 2.1% | -68.7% | ||
| Q1 25 | 1.1% | -10.3% | ||
| Q4 24 | 2.3% | 17.6% | ||
| Q3 24 | 1.5% | 20.4% | ||
| Q2 24 | 1.6% | 16.5% | ||
| Q1 24 | 0.2% | -1.6% |
每股收益（稀释后）CHEFJAZZ
| Q4 25 | $0.50 | $3.34 | ||
| Q3 25 | $0.44 | $4.08 | ||
| Q2 25 | $0.49 | $-11.74 | ||
| Q1 25 | $0.25 | $-1.52 | ||
| Q4 24 | $0.56 | $2.97 | ||
| Q3 24 | $0.34 | $3.42 | ||
| Q2 24 | $0.37 | $2.49 | ||
| Q1 24 | $0.05 | $-0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $121.0M | $1.4B |
| 总债务越低越好 | $720.3M | $5.4B |
| 股东权益账面价值 | $604.3M | $4.3B |
| 总资产 | $2.0B | $11.7B |
| 负债/权益比越低杠杆越低 | 1.19× | 1.24× |
8季度趋势，按日历期对齐
现金及短期投资CHEFJAZZ
| Q4 25 | $121.0M | $1.4B | ||
| Q3 25 | $65.1M | $1.3B | ||
| Q2 25 | $96.9M | $1.2B | ||
| Q1 25 | $116.5M | $1.9B | ||
| Q4 24 | $114.7M | $2.4B | ||
| Q3 24 | $50.7M | $2.2B | ||
| Q2 24 | $38.3M | $1.4B | ||
| Q1 24 | $42.3M | $1.4B |
总债务CHEFJAZZ
| Q4 25 | $720.3M | $5.4B | ||
| Q3 25 | $711.7M | $5.4B | ||
| Q2 25 | $690.2M | $5.4B | ||
| Q1 25 | $681.1M | $5.4B | ||
| Q4 24 | $688.7M | $6.1B | ||
| Q3 24 | $666.6M | $6.1B | ||
| Q2 24 | $660.8M | $5.7B | ||
| Q1 24 | $667.3M | $5.7B |
股东权益CHEFJAZZ
| Q4 25 | $604.3M | $4.3B | ||
| Q3 25 | $576.6M | $4.0B | ||
| Q2 25 | $557.7M | $3.7B | ||
| Q1 25 | $541.6M | $4.2B | ||
| Q4 24 | $537.6M | $4.1B | ||
| Q3 24 | $480.3M | $4.2B | ||
| Q2 24 | $461.9M | $3.8B | ||
| Q1 24 | $447.8M | $3.7B |
总资产CHEFJAZZ
| Q4 25 | $2.0B | $11.7B | ||
| Q3 25 | $1.9B | $11.4B | ||
| Q2 25 | $1.9B | $10.9B | ||
| Q1 25 | $1.8B | $11.5B | ||
| Q4 24 | $1.9B | $12.0B | ||
| Q3 24 | $1.8B | $12.3B | ||
| Q2 24 | $1.7B | $11.4B | ||
| Q1 24 | $1.7B | $11.3B |
负债/权益比CHEFJAZZ
| Q4 25 | 1.19× | 1.24× | ||
| Q3 25 | 1.23× | 1.35× | ||
| Q2 25 | 1.24× | 1.45× | ||
| Q1 25 | 1.26× | 1.29× | ||
| Q4 24 | 1.28× | 1.49× | ||
| Q3 24 | 1.39× | 1.47× | ||
| Q2 24 | 1.43× | 1.52× | ||
| Q1 24 | 1.49× | 1.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.9M | $362.5M |
| 自由现金流经营现金流 - 资本支出 | $65.8M | $345.8M |
| 自由现金流率自由现金流/营收 | 5.8% | 28.9% |
| 资本支出强度资本支出/营收 | 0.7% | 1.4% |
| 现金转化率经营现金流/净利润 | 3.41× | 1.78× |
| 过去12个月自由现金流最近4个季度 | $87.8M | $1.3B |
8季度趋势，按日历期对齐
经营现金流CHEFJAZZ
| Q4 25 | $73.9M | $362.5M | ||
| Q3 25 | $-8.7M | $474.6M | ||
| Q2 25 | $14.5M | $88.9M | ||
| Q1 25 | $49.6M | $429.8M | ||
| Q4 24 | $73.0M | $398.6M | ||
| Q3 24 | $19.8M | $398.7M | ||
| Q2 24 | $29.3M | $331.4M | ||
| Q1 24 | $30.9M | $267.2M |
自由现金流CHEFJAZZ
| Q4 25 | $65.8M | $345.8M | ||
| Q3 25 | $-19.7M | $459.4M | ||
| Q2 25 | $4.5M | $75.9M | ||
| Q1 25 | $37.2M | $415.9M | ||
| Q4 24 | $64.6M | $385.3M | ||
| Q3 24 | $11.8M | $388.0M | ||
| Q2 24 | $13.3M | $324.3M | ||
| Q1 24 | $13.8M | $260.3M |
自由现金流率CHEFJAZZ
| Q4 25 | 5.8% | 28.9% | ||
| Q3 25 | -1.9% | 40.8% | ||
| Q2 25 | 0.4% | 7.3% | ||
| Q1 25 | 3.9% | 46.3% | ||
| Q4 24 | 6.3% | 35.4% | ||
| Q3 24 | 1.3% | 36.8% | ||
| Q2 24 | 1.4% | 31.7% | ||
| Q1 24 | 1.6% | 28.9% |
资本支出强度CHEFJAZZ
| Q4 25 | 0.7% | 1.4% | ||
| Q3 25 | 1.1% | 1.3% | ||
| Q2 25 | 1.0% | 1.2% | ||
| Q1 25 | 1.3% | 1.5% | ||
| Q4 24 | 0.8% | 1.2% | ||
| Q3 24 | 0.9% | 1.0% | ||
| Q2 24 | 1.7% | 0.7% | ||
| Q1 24 | 2.0% | 0.8% |
现金转化率CHEFJAZZ
| Q4 25 | 3.41× | 1.78× | ||
| Q3 25 | -0.46× | 1.89× | ||
| Q2 25 | 0.68× | — | ||
| Q1 25 | 4.82× | — | ||
| Q4 24 | 3.05× | 2.09× | ||
| Q3 24 | 1.41× | 1.85× | ||
| Q2 24 | 1.89× | 1.97× | ||
| Q1 24 | 16.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHEF
| Center Of The Plate Product | $459.1M | 40% |
| Dry Goods Product | $175.7M | 15% |
| Pastry Product | $160.5M | 14% |
| Produce | $147.9M | 13% |
| Cheese And Charcuterie Product | $75.3M | 7% |
| Dairy And Eggs Product | $69.2M | 6% |
| Oils And Vinegar Product | $32.4M | 3% |
| Kitchen Supplies Product | $22.4M | 2% |
JAZZ
| Xywav | $465.5M | 39% |
| Total Oncology | $337.8M | 28% |
| Rylaze Enrylaze | $108.2M | 9% |
| Zepzelca | $90.4M | 8% |
| Product And Services Royalties And Contract Revenue | $65.5M | 5% |
| High Sodium AG Oxybate Product Royalty Revenue | $55.7M | 5% |
| Xyrem | $37.8M | 3% |
| Vyxeos | $34.7M | 3% |
| Ziihera | $8.5M | 1% |
| Other Products | $2.8M | 0% |
| Sativex | $1.5M | 0% |
